Ketorolac Tromethamine
Product Images NDC 0338-0076

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Ketorolac Tromethamine (NDC 0338-0076). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ketorolac Tromethamine Structural Formula (Image 01)

FDA Label Image

Image 011

FDA Label Image

Ketorolac Representaive Container Label 0338-0069-10 (Image 02)

Ketorolac Representaive Container Label 0338-0069-10 (Image 02)
This is a description of the drug Ketorolac, which is a prescription-only medicine with National Drug Code (NDC) 0338-0069-10. It is an injection manufactured by Baxter Healthcare Corporation, containing tromethamine and magnesium, with a concentration of 15mg/mL. The drug is meant for intravenous or intramuscular administration with each vial containing 1mL. The batch number details are missing, and the code number is TWDRUGS/TNOD0U457.*
FDA Label Image

Ketorolac Representaive Container Label 0338-0072-25 (Image 03)

Ketorolac Representaive Container Label 0338-0072-25 (Image 03)
This is a description of a pharmaceutical product sold in Baxter Single Dose vials. The vials contain a solution of an unspecified medication at 15 mg/mL concentration, intended for intravenous or intramuscular administration. The product appears to be associated with the initials "LGB TR" and the numeric code "ND 0". The only other information provided is a measurement of 44.00 mm, which is not relevant to the product description.*
FDA Label Image

Ketorolac Representaive Container Label 0338-0076-10 (Image 04)

Ketorolac Representaive Container Label 0338-0076-10 (Image 04)
This is a drug information label for Ketorolac Tromethamine Injection. It contains details about the dosage, storage conditions and usage for the drug. It is intended for intravenous and intramuscular use. The drug is available in packs of 10 x 1mL Baxter single dose vials.*
FDA Label Image

Image 05

Image 05
This is a description of a medication with the National Drug Code 0338-0072-25. The medication is called Tromethamine and is an injection that can be used intravenously or intramuscularly. The injection is manufactured by Baxter Healthcare Corporation and comes in a single-dose vial of 1 mL. The concentration of this medication is 30 mg/mL. There is no detailed information about the batch number.*
FDA Label Image

Image 06

Image 06
This is a description of a Ketorolac Tromethamine Injection, USP with a 30mg dose in single-use vials of 250 1mL. The injection is suitable for Intravenous or Intramuscular use and the vials have a dimension of 90x90 mm. The text also includes the code "NUvz" and a measurement of 44.00 mm, but their significance is unclear.*
FDA Label Image

Image 07

Image 07
This is a medication called Sterie containing Ketorokac Tromethamine and sodium chloride. It is intended for intravenous or intramuscular use and is available in single-dose vials. The medication should be stored in a cool, dry place and protected from light. The recommended dosage is provided in the package insert. This medication is produced by Baxter Corporation and is made in India.*
FDA Label Image

Image 08

Image 08
Description: Ketorolac is a drug that comes in a single dose vial with a strength of 30mg/mL and is intended for intramuscular use only. Manufactured by Baxter Healthcare Corporation in Deerfield, IL, USA, this injection is identified by the National Drug Code (NDC) number 0338-0076-10 and the product code TWORI™IOO04ST. The batch number details are not available. This product is available only with a prescription.*
FDA Label Image

Image 09

Image 09
This is a description of an injectable medication in a vial format. It is intended for intramuscular injection only and each vial contains 2 milliliters of the medication. The vials are sold in packs of 10 and are from the brand Baxter. The measurement of the vial is 44.00 millimeters.*
FDA Label Image

Image 10

Image 10
This is a description of a drug called Ketorolac Tromethamine that comes in a 60mg/2mL solution (30mg/mL) and is intended for intramuscular use only. The package contains 10 single dose vials of 2mL each. Other details including dosage instructions, usage precautions or other relevant information are not available.*
FDA Label Image

Image 12

Image 12
The text describes a medication named Ketorolac Tromethamine, available in a bottle with NDC number 0338007225. The medication is manufactured in the USA and has a concentration of 30mg/mL. The medication must be stored at a controlled room temperature between 20° to 26°C (68° to 77°F). The bottle’s expiration date is December 31, 2020, and the bottle number is T0070119 with a quantity of 72. The text includes a barcode with a reference number 50303380072250 and several numbers and letters that are not understandable.*
FDA Label Image

Image 13

Image 13
This appears to be the label of a medication called Katorolac Tromethamine with a strength of 60mg/2mL. It contains information regarding the storage temperature, expiration date, lot number, and quantity. The manufacturer is Baxter in the USA. The text also includes a phone number, likely for customer service.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.